Inhibition of glutathione efflux in the perfused rat liver and isolated hepatocytes by organic anions and bilirubin. Kinetics, sidedness, and molecular forms.
Using isolated, in situ, single-pass perfused rat livers, incubations of freshly isolated hepatocytes, and sinusoidal membrane-enriched vesicles, we and others have shown the saturability of transport (efflux) of hepatic glutathione (GSH). These observations have implicated a carrier mechanism. Our present studies were designed to provide further evidence in support of a carrier mechanism for hepatic GSH efflux by demonstrating competition by liver-specific ligands which are taken up by hepatocytes. Perfusing livers with different substances, we found that: (a) sulfobromophthalein-GSH (BSP-GSH) had a dose-dependent and fully reversible inhibitory effect on GSH efflux, while GSH alone did not have any effect; (b) taurocholate had no inhibitory effect; (c) all of the organic anions studied, i.e., BSP, rose bengal, indocyanine green, and unconjugated bilirubin (UCB), manifested potent, dose-dependent inhibitory effects, with absence of toxic effects and complete reversibility of inhibition in the case of UCB. The inhibitory effects of UCB could be overcome partially by raising (CoCl2-induced) hepatic GSH concentration. Because of the physiological importance of UCB, we conducted a detailed study of its inhibitory kinetics in the isolated hepatocyte model in the range of circulating concentrations of UCB. Studies with Cl- -free media, to inhibit the uptake of UCB by hepatocytes, showed that the inhibition of GSH efflux by UCB is apparently from inside the cell. This point was confirmed by showing that the inhibition is overcome only when bilirubin-loaded cells are cleared of bilirubin (incubation with 5% bovine serum albumin). Using Gunn rat hepatocytes and purified bilirubin mono- and diglucuronides, we found that both UCB and glucuronide forms of bilirubin inhibit GSH efflux in a dose-dependent manner. We conclude that the organic anions, although taken up by a mechanism independent of GSH, may competitively inhibit the carrier for GSH efflux from inside the hepatocyte.
Ookhtens
M
M
Liver Research Laboratory, Veterans Administration Wadsworth Medical Center, Los Angeles, California 90073.
Lyon
I
I
Fernandez-Checa
J
J
Kaplowitz
N
N
D000818:Animals; D001647:Bile Acids and Salts / Q000494:pharmacology; D001663:Bilirubin / Q000031:analogs & derivatives / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D002469:Cell Separation; D005456:Fluorescent Dyes / Q000494:pharmacology*; D005978:Glutathione / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D010477:Perfusion; D051381:Rats; D011911:Rats, Gunn; D011919:Rats, Inbred Strains; D013448:Sulfobromophthalein / Q000494:pharmacology
D001647:Bile Acids and Salts; D005456:Fluorescent Dyes; D013448:Sulfobromophthalein; C016266:bilirubin glucuronate; C035816:(sulfobromophthalein)glutathione conjugate; D005978:Glutathione; D001663:Bilirubin